Budget constraints limit FDA inspections
Tuesday, October 12, 2010 - 09:31
in Health & Medicine
Budgetary constraints are one of the principal factors that limit the US Food & Drug Administration's ability to conduct frequent and rigorous site inspections of pharmaceutical manufacturers, according to research published in the International Journal of Business Continuity and Risk Management.